Pacer Advisors Inc. Has $670,000 Stock Position in Maximus, Inc. (NYSE:MMS)

Pacer Advisors Inc. lessened its stake in Maximus, Inc. (NYSE:MMS - Free Report) by 29.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 8,973 shares of the health services provider's stock after selling 3,714 shares during the quarter. Pacer Advisors Inc.'s holdings in Maximus were worth $670,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in the stock. V Square Quantitative Management LLC acquired a new stake in shares of Maximus in the 3rd quarter valued at approximately $25,000. UMB Bank n.a. boosted its position in shares of Maximus by 79.8% during the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider's stock worth $27,000 after purchasing an additional 158 shares in the last quarter. Eastern Bank acquired a new position in shares of Maximus in the 4th quarter valued at $29,000. GAMMA Investing LLC increased its position in shares of Maximus by 150.6% in the 3rd quarter. GAMMA Investing LLC now owns 862 shares of the health services provider's stock valued at $80,000 after buying an additional 518 shares in the last quarter. Finally, Quarry LP grew its stake in Maximus by 48.0% in the third quarter. Quarry LP now owns 1,017 shares of the health services provider's stock valued at $95,000 after acquiring an additional 330 shares during the period. Institutional investors and hedge funds own 97.21% of the company's stock.

Insider Transactions at Maximus

In other Maximus news, Director Raymond B. Ruddy purchased 3,490 shares of the company's stock in a transaction that occurred on Thursday, December 12th. The shares were acquired at an average price of $71.46 per share, for a total transaction of $249,395.40. Following the purchase, the director now owns 112,520 shares in the company, valued at approximately $8,040,679.20. The trade was a 3.20 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Michelle F. Link sold 2,208 shares of Maximus stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $73.83, for a total transaction of $163,016.64. Following the transaction, the insider now directly owns 6,567 shares of the company's stock, valued at approximately $484,841.61. This trade represents a 25.16 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have purchased a total of 7,063 shares of company stock worth $502,017 in the last 90 days. Corporate insiders own 1.60% of the company's stock.

Maximus Stock Down 0.2 %

Maximus stock traded down $0.14 during midday trading on Friday, reaching $69.86. The stock had a trading volume of 1,378,914 shares, compared to its average volume of 729,773. The stock has a market capitalization of $3.99 billion, a P/E ratio of 13.97 and a beta of 0.72. The firm's fifty day simple moving average is $74.73 and its 200-day simple moving average is $83.38. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.49 and a current ratio of 1.49. Maximus, Inc. has a 1-year low of $68.30 and a 1-year high of $93.97.

Maximus (NYSE:MMS - Get Free Report) last released its earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, beating analysts' consensus estimates of $1.39 by $0.22. Maximus had a net margin of 5.78% and a return on equity of 20.95%. As a group, analysts expect that Maximus, Inc. will post 5.95 EPS for the current fiscal year.

Maximus Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 28th. Shareholders of record on Saturday, February 15th will be given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 1.72%. The ex-dividend date of this dividend is Friday, February 14th. Maximus's dividend payout ratio (DPR) is 24.00%.

Analyst Ratings Changes

MMS has been the topic of a number of research analyst reports. Raymond James raised Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price target on the stock in a research report on Thursday, January 2nd. StockNews.com upgraded shares of Maximus from a "hold" rating to a "buy" rating in a report on Thursday.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.